Porcilis Glässer is a vaccine used for active immunisation of pigs to reduce typical lesions of Glässer’s disease caused by Haemophilus parasuis serotype 5. The vaccine is of benefit when animals with no or low levels of antibodies against H. parasuis serotype 5 are mixed with pigs from or in an environment with a high prevalence of Glässer’s disease.
Aqueous, white or nearly white suspension for injection
Per 2 ml dose:
- Inactivated whole bacterial cells of Haemophilus parasuis serotype 5, strain 4800: 0.05 mg total nitrogen, inducing ≥ 9.1 Elisa Units*.
- Adjuvant: 150 mg dl-α-tocopheryl acetate.
* ELISA units = mean antibody titre (log2 value) in the potency test in mice.
Indications for use
Active immunisation of pigs to reduce typical lesions of Glässer’s disease caused by Haemophilus parasuis serotype 5.
Onset of immunity: 2 weeks after completion of vaccination.
Duration of immunity: 14 weeks after completion of vaccination.
For passive immunisation of the progeny of vaccinated sows and gilts to reduce infection, mortality, clinical signs and typical lesions of Glässer disease caused by H. parasuis serotype 5 and to reduce clinical signs and mortality caused by H. parasuis serotype 4.
Onset of immunity: After birth and sufficient uptake of colostrum.
Duration of immunity has been demonstrated at 4 weeks of age against serotype 4 and at 6 weeks of age against serotype 5.
Pigs – meat 0 days
50 ml (25 doses) Glass type I or PET vials
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018